Clinical Trial

A Drug-drug Interaction Study to Investigate the Pharmacokinetic Interactions Between CKD-508, Midazolam, and Rosuvastatin in Healthy Adult Male Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
Phase 1, open-label, non-randomized, three-treatment, one-sequence interaction study to evaluate the PK interactions between CKD-508, midazolam, and rosuvastatin in healthy adult male participants
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-18.
Status change: Not Yet Recruiting → Completed 2026-02-25
Trial Details
NCT Number NCT06979973
Lead Sponsor Chong Kun Dang Pharmaceutical
Conditions Healthy
Enrollment 24 participants
Start Date 2025-05-14
Primary Completion 2025-08-17 (estimated)
Study Completion 2025-08-17 (estimated)
Updated on ClinicalTrials.gov 2026-02-27